Jain Global’s Agios Pharmaceuticals AGIO Stock Holding History

Jain Global’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,749	Closed	-$258K	–	987
2025 Q2	$258K	Buy	+7,749	New	+$235K	﹤0.01%	925

Other funds holding AGIO

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jain Global's AGIO Position: Q3 2025 in Review

Jain Global sold out of Agios Pharmaceuticals (AGIO) in Q3 2025, closing a stake of 7,749 shares — an estimated $258K sold.

Jain Global first reported a position in AGIO in Q2 2025 and held it in 1 quarter. The position peaked at $258K in Q2 2025. 220 funds tracked by Wall St. Rank hold AGIO as of Q3 2025.

Jain Global reported no remaining Agios Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Jain Global sold 7,749 Agios Pharmaceuticals shares in Q3 2025, an estimated $258K.
Jain Global first reported a position in Agios Pharmaceuticals in Q2 2025 and held it in 1 quarter.
Jain Global's Agios Pharmaceuticals position peaked at $258K in Q2 2025.
220 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.